John,

If passed, our Build Back Better investment agenda will implement a wide range of historic accomplishments. One of the most important features would allow Medicare to directly negotiate drug prices with pharmaceutical companies.

This is enormously popular and could generate up to $500 billion in taxpayer savings to the federal government.

Those savings would make it possible to expand health care for more Americans, including Medicaid coverage for poor people denied care in many states, and dental, vision, and hearing coverage in Medicare.

Here's the problem: If the drug pricing element gets removed from the Build Back Better Act, it would create a massive hole in the budget—making it much harder to deliver on all our priorities. Add your name! Join CHN and our growing national coalition to send a message to Congress: Say NO to Big Pharma. Medicare must negotiate prescription drug prices.

A handful of corporate Democrats are putting Big Pharma lobbyists and contributors over their own constituents and holding up critical Build Back Better investments. That's not acceptable.

We must put pressure on all representatives and senators and remind them that they work for us, not Big Pharma. We’re sending thousands of letters to members of Congress to pass this critical legislation and go BIG and BOLD.

Together, let's demand Congress say "NO" to Big Pharma. Medicare must negotiate prescription drug prices. Send a message to your senators and representative today!

Thank you for all you do to demand accountability from our political leaders and to fight for the needs of the vulnerable, the sick and the poor.

Deborah Weinstein
Executive Director, Coalition on Human Needs